文献速递呼吸危重症与机械通气

持续气道正压通气与经鼻高流量氧疗治疗急性低氧性呼吸衰竭的随机对照试验

Continuous positive airway pressure versus high-flow nasal cannula oxygen therapy for acute hypoxemic respiratory failure: A randomized controlled trial.
PubMed 文献 · Respirology · 2023-08-30

这项多中心、开放标签、平行组随机对照试验比较了CPAP与HFNC对急性低氧性呼吸衰竭患者达到预设插管标准风险的影响。与HFNC相比,CPAP降低了达到插管标准的风险(HR 0.327;95%CI 0.148-0.724;p=0.006)。

要点

  • CPAP较HFNC显著降低急性低氧性呼吸衰竭患者28天内达到插管标准的风险(HR 0.327)。
  • 两组插管率、住院和28天死亡率、无呼吸机天数等无显著差异。
  • CPAP组氧合显著更优,但pH更低、二氧化碳分压更高。

核心结论

  • 在急性低氧性呼吸衰竭患者中,CPAP比HFNC更能降低达到预设插管标准的风险。

主要发现

  • 与HFNC相比,CPAP降低达到插管标准的风险(HR 0.327;95%CI 0.148-0.724;p=0.006)。
  • 两组插管率、住院和28天死亡率、无呼吸机天数、呼吸支持需求持续时间及因呼吸疾病住院时间无显著差异。
  • CPAP组肺氧合显著更好,pH显著更低、二氧化碳分压显著更高,但两组呼吸频率无差异。
  • CPAP和HFNC均与少量可能相关的不良事件有关。

临床怎么用

  • 对于急性低氧性呼吸衰竭患者,可优先考虑CPAP以降低达到插管标准的风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: The relative effectiveness of initial non-invasive respiratory strategies for acute respiratory failure using continuous positive airway pressure (CPAP) or high-flow nasal cannula (HFNC) is unclear. METHODS: We conducted a multicenter, open-label, parallel-group randomized controlled trial to compare the efficacy of CPAP and HFNC on reducing the risk of meeting the prespecified criteria for intubation and improving clinical outcomes of acute hypoxemic respiratory failure. The primary endpoint was the time taken to meet the prespecified criteria for intubation within 28 days. RESULTS: Eighty-five patients were randomly assigned to the CPAP or HFNC group. Eleven (28.9%) in the CPAP group and twenty (42.6%) in the HFNC group met the criteria for intubation within 28 days. Compared with HFNC, CPAP reduced the risk of meeting the intubation criteria (hazard ratio [HR], 0.327; 95% CI, 0.148-0.724; p = 0.006). There were no significant between-group differences in the intubation rates, in-hospital and 28-day mortality rates, ventilator-free days, duration of the need for respiratory support, or duration of hospitalization for respiratory illness. Pulmonary oxygenation was significantly better in the CPAP group, with significantly lower pH and higher partial pressure of carbon dioxide, but there were no differences in the respiratory rate between groups. CPAP and HFNC were associated with few possibly causal adverse events. CONCLUSION: CPAP is more effective than HFNC at reducing the risk of meeting the intubation criteria in patients with acute hypoxemic respiratory failure.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Nagata K, Yokoyama T, Tsugitomi R, et al. Continuous positive airway pressure versus high-flow nasal cannula oxygen therapy for acute hypoxemic respiratory failure: A randomized controlled trial. Respirology. 2023. PMID: 37648252. doi:10.1111/resp.14588

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。